myeloid lines daudi Search Results


95
ATCC myeloid lines daudi
Myeloid Lines Daudi, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myeloid+lines+daudi/Toledo/bio_rxiv__64898__2026__03__16__712182-202-13-24
Average 95 stars, based on 1 article reviews
myeloid lines daudi - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

98
ATCC burkitt s lymphoma tumor cell line daudi
IL-15 DCs superiorly attract cytotoxic immune effector cells ( A ). Floating bars (min to max, line at mean) represent % granzyme B+ cells in PBMC (white bar), PBMC exposed for 3 hours to 48-hour wash-out supernatant of IL-15 DCs (striped dark grey bar) or IL-4 DCs (striped light grey bar), and PBMC following IL-15 DC- (dark grey bar) or IL-4 DC-mediated (light grey bar) migration ( n = 3). ( B ) Representation of % granzyme B+ cells (+ SD) within the different effector cell subsets in full PBMC fraction (white bars) and following IL15 DC- (dark grey bars) or IL-4 DC-mediated (light grey bars) migration ( n = 8). ( C ) Cytotoxicity was determined of migrated purified γδ T cells and NK cells towards 48-hour wash-out supernatant of IL-15 DCs (IL-15 DCs) or IL4 DCs (IL-4 DCs). Non-migrated purified cells (-) were used to define control killing capacity. <t>Daudi</t> and K562 target cells were added at an E:T ratio of 5:1 γδ T cells and 1:1 NK cells, respectively. Percentage tumor cell killing was determined by Annexin-V/PI staining after 4 hours and calculated using the formula specified in “Materials and methods”. Donors are represented by unique symbols ( n = 6). Repeated measures ANOVA with Bonferroni›s Multiple Comparison Test. *** p < 0.001, ** p < 0.01, * p < 0.05, ns, p > 0.5.
Burkitt S Lymphoma Tumor Cell Line Daudi, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myeloid+lines+daudi/Daudi/pmc05355127-141-1-38
Average 98 stars, based on 1 article reviews
burkitt s lymphoma tumor cell line daudi - by Bioz Stars, 2026-09
98/100 stars
  Buy from Supplier

94
DSMZ burkitt lymphoma cell line
IL-15 DCs superiorly attract cytotoxic immune effector cells ( A ). Floating bars (min to max, line at mean) represent % granzyme B+ cells in PBMC (white bar), PBMC exposed for 3 hours to 48-hour wash-out supernatant of IL-15 DCs (striped dark grey bar) or IL-4 DCs (striped light grey bar), and PBMC following IL-15 DC- (dark grey bar) or IL-4 DC-mediated (light grey bar) migration ( n = 3). ( B ) Representation of % granzyme B+ cells (+ SD) within the different effector cell subsets in full PBMC fraction (white bars) and following IL15 DC- (dark grey bars) or IL-4 DC-mediated (light grey bars) migration ( n = 8). ( C ) Cytotoxicity was determined of migrated purified γδ T cells and NK cells towards 48-hour wash-out supernatant of IL-15 DCs (IL-15 DCs) or IL4 DCs (IL-4 DCs). Non-migrated purified cells (-) were used to define control killing capacity. <t>Daudi</t> and K562 target cells were added at an E:T ratio of 5:1 γδ T cells and 1:1 NK cells, respectively. Percentage tumor cell killing was determined by Annexin-V/PI staining after 4 hours and calculated using the formula specified in “Materials and methods”. Donors are represented by unique symbols ( n = 6). Repeated measures ANOVA with Bonferroni›s Multiple Comparison Test. *** p < 0.001, ** p < 0.01, * p < 0.05, ns, p > 0.5.
Burkitt Lymphoma Cell Line, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/myeloid+lines+daudi/DAUDI/pmc10249581-83-1-20
Average 94 stars, based on 1 article reviews
burkitt lymphoma cell line - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


IL-15 DCs superiorly attract cytotoxic immune effector cells ( A ). Floating bars (min to max, line at mean) represent % granzyme B+ cells in PBMC (white bar), PBMC exposed for 3 hours to 48-hour wash-out supernatant of IL-15 DCs (striped dark grey bar) or IL-4 DCs (striped light grey bar), and PBMC following IL-15 DC- (dark grey bar) or IL-4 DC-mediated (light grey bar) migration ( n = 3). ( B ) Representation of % granzyme B+ cells (+ SD) within the different effector cell subsets in full PBMC fraction (white bars) and following IL15 DC- (dark grey bars) or IL-4 DC-mediated (light grey bars) migration ( n = 8). ( C ) Cytotoxicity was determined of migrated purified γδ T cells and NK cells towards 48-hour wash-out supernatant of IL-15 DCs (IL-15 DCs) or IL4 DCs (IL-4 DCs). Non-migrated purified cells (-) were used to define control killing capacity. Daudi and K562 target cells were added at an E:T ratio of 5:1 γδ T cells and 1:1 NK cells, respectively. Percentage tumor cell killing was determined by Annexin-V/PI staining after 4 hours and calculated using the formula specified in “Materials and methods”. Donors are represented by unique symbols ( n = 6). Repeated measures ANOVA with Bonferroni›s Multiple Comparison Test. *** p < 0.001, ** p < 0.01, * p < 0.05, ns, p > 0.5.

Journal: Oncotarget

Article Title: Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells

doi: 10.18632/oncotarget.14622

Figure Lengend Snippet: IL-15 DCs superiorly attract cytotoxic immune effector cells ( A ). Floating bars (min to max, line at mean) represent % granzyme B+ cells in PBMC (white bar), PBMC exposed for 3 hours to 48-hour wash-out supernatant of IL-15 DCs (striped dark grey bar) or IL-4 DCs (striped light grey bar), and PBMC following IL-15 DC- (dark grey bar) or IL-4 DC-mediated (light grey bar) migration ( n = 3). ( B ) Representation of % granzyme B+ cells (+ SD) within the different effector cell subsets in full PBMC fraction (white bars) and following IL15 DC- (dark grey bars) or IL-4 DC-mediated (light grey bars) migration ( n = 8). ( C ) Cytotoxicity was determined of migrated purified γδ T cells and NK cells towards 48-hour wash-out supernatant of IL-15 DCs (IL-15 DCs) or IL4 DCs (IL-4 DCs). Non-migrated purified cells (-) were used to define control killing capacity. Daudi and K562 target cells were added at an E:T ratio of 5:1 γδ T cells and 1:1 NK cells, respectively. Percentage tumor cell killing was determined by Annexin-V/PI staining after 4 hours and calculated using the formula specified in “Materials and methods”. Donors are represented by unique symbols ( n = 6). Repeated measures ANOVA with Bonferroni›s Multiple Comparison Test. *** p < 0.001, ** p < 0.01, * p < 0.05, ns, p > 0.5.

Article Snippet: The Burkitt's lymphoma tumor cell line Daudi was kindly provided to us by the laboratory of Prof. Kris Thielemans (Free University of Brussels, Brussels, Belgium) and the chronic myeloid leukemia tumor cell line K562 was obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA; catalogue number: K-562 ATCC ® CCL243 TM ).

Techniques: Migration, Purification, Control, Staining, Comparison